Literature DB >> 33913073

Non-Invasive Markers in Non-Alcoholic Fatty Liver Disease: Reliability Is Variable According to BMI Status.

Laísa Simakawa Jimenez1, Rodolfo Araújo Marques1, Martinho A Gestic1, Murillo P Utrini1, Felipe D M Chaim1, Almino C Ramos1, Elinton A Chaim1, Everton Cazzo2.   

Abstract

Entities:  

Keywords:  Biomarkers; Fatty liver; Liver function tests; Non-alcoholic fatty hepatopathy; Obesity

Mesh：

Substances：

Year:  2021        PMID： 33913073     DOI： 10.1007/s11695-021-05429-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  6 in total

1.  Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity.

Authors:  Chi-Ming Tai; Ming-Lung Yu; Hung-Pin Tu; Chih-Kun Huang; Jau-Chung Hwang; Wan-Long Chuang
Journal:  Surg Obes Relat Dis       Date:  2016-12-07       Impact factor: 4.734

2.  Bilobar Hepatic Histological Variability in Obese Individuals Undergoing Bariatric Surgery: an Analysis of Paired Wedge Biopsies.

Authors:  Pedro H F Sousa-Filho; Laísa S Jimenez; Guilherme H Callejas; Matheus M Concon; João G R Braga; Rodolfo A Marques; Felipe D M Chaim; Martinho A Gestic; Murillo P Utrini; Almino C Ramos; Elinton A Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2020-09-18       Impact factor: 4.129

3.  APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.

Authors:  Frederik Cornelis Kruger; Caroline Rachel Daniels; Martin Kidd; Gillaum Swart; Karen Brundyn; Christo van Rensburg; Maritha Kotze
Journal:  S Afr Med J       Date:  2011-06-27

4.  Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease.

Authors:  Jeong-Hoon Lee; Donghee Kim; Hwa Jung Kim; Chang-Hoon Lee; Jong In Yang; Won Kim; Yoon Jun Kim; Jung-Hwan Yoon; Sang-Heon Cho; Myung-Whun Sung; Hyo-Suk Lee
Journal:  Dig Liver Dis       Date:  2009-09-18       Impact factor: 4.088

5.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

6.  The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.

Authors:  Paul Angulo; Jason M Hui; Giulio Marchesini; Ellisabetta Bugianesi; Jacob George; Geoffrey C Farrell; Felicity Enders; Sushma Saksena; Alastair D Burt; John P Bida; Keith Lindor; Schuyler O Sanderson; Marco Lenzi; Leon A Adams; James Kench; Terry M Therneau; Christopher P Day
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425
  6 in total
  1 in total

1.  The association between NAFLD and risk of chronic kidney disease: a cross-sectional study.

Authors:  Ying Cao; You Deng; Jingjing Wang; Hong Zhao; Jingyu Zhang; Wen Xie
Journal:  Ther Adv Chronic Dis       Date:  2021-11-09       Impact factor: 5.091
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.